Skip to main content

Petco Health Wellness Company Inc

For the period ended Aug 3, 2024. Filed Sep 10, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Aug 3, 2024 · Filed Sep 10, 2024

WOOF$2.93-5.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

Twenty-six weeks ended
August 3,2024July 29,2023
Cash flows from operating activities:
Net loss$(71,306)$(16,498)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization99,30597,919
Amortization of debt discounts and issuance costs2,4352,446
Provision for deferred taxes(27,782)(11,002)
Equity-based compensation29,34846,248
Impairments, write-offs and losses on sale of fixed and other assets7,0691,035
Loss on partial extinguishment of debt—746
Income from equity method investees(9,077)(6,458)
Amounts reclassified out of accumulated other comprehensive (loss) income(2,274)1,055
Non-cash operating lease costs207,605211,576
Other non-operating loss (income)2,665(4,614)
Changes in assets and liabilities:
Receivables(2,083)(16,679)
Merchandise inventories11,769(23,011)
Prepaid expenses and other assets(7,166)(14,237)
Accounts payable and book overdrafts(9,644)97,062
Accrued salaries and employee benefits34,5911,221
Accrued expenses and other liabilities3,015(1,238)
Operating lease liabilities(209,738)(232,518)
Other long-term liabilities2,2241,212
Net cash provided by operating activities60,956134,265
Cash flows from investing activities:
Cash paid for fixed assets(60,029)(114,023)
Cash paid for acquisitions, net of cash acquired(259)(2,040)
Proceeds from investment99810,248
Proceeds from sale of assets1,019—
Cash received from partial surrender of officers' life insurance206—
Net cash used in investing activities(58,065)(105,815)
Cash flows from financing activities:
Borrowings under long-term debt agreements201,000—
Repayments of long-term debt(201,000)(60,000)
Debt refinancing costs(3,028)—
Payments for finance lease liabilities(3,528)(3,349)
Proceeds from employee stock purchase plan and stock option exercises1,6302,454
Tax withholdings on stock-based awards(3,468)(4,873)
Proceeds from issuance of common stock2,500—
Net cash used in financing activities(5,894)(65,768)
Net decrease in cash, cash equivalents and restricted cash(3,003)(37,318)
Cash, cash equivalents and restricted cash at beginning of period136,649213,727
Cash, cash equivalents and restricted cash at end of period$133,646$176,409
Supplemental cash flow disclosures:
Interest paid, net$69,399$72,005
Income taxes paid$15,581$27,423
Supplemental non-cash investing and financing activities disclosure:
Accounts payable and accrued expenses for capital expenditures$15,684$30,336
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.